| GlaxoSmithKline steigt bei Preispoker mit den Kassen in Deutschland aus (dpa-afx) |
| GlaxoSmithKline Takes Human Genome Bid Hostile: Hot Trends (EN, TheStreet.com) |
| GlaxoSmithKline to Get Hostile with Offer for Human Genome (EN, Benzinga earnings) |
| GlaxoSmithKline: Feindliches Übernahmeangebot für Human Genome Science (dpa-afx) 
Der britische Pharmariese GlaxoSmithKline will nach der Ablehnung seiner Übernahmeofferte für Human Genome Sciences nun den feindlichen Weg gehen. mehr |
| 4-Star Stocks Poised to Pop: GlaxoSmithKline (EN, MotleyFool) |
| GlaxoSmithKline Dives on Weak Growth (EN, MotleyFool) |
| GlaxoSmithKline shares drop on Q1 disappointment (EN, Yahoo) |
| GSK: Quartalsgewinn rückläufig (Aktiencheck) |
| GlaxoSmithKline Q1 profit down 13 pct (EN, Yahoo) |
| Human Genome rejects bid by GlaxoSmithKline of US$2.6 bil. (EN, Chinapost) |
| DealBook: Human Genome Sciences Rejects Offer From GlaxoSmithKline (EN, New York Times) |
| Human Genome Rejects $2.6B Bid From GlaxoSmithKline (EN, TheStreet.com) |
| GlaxoSmithKline Boosts Stake in Theravance (EN, TheStreet.com) |
| GlaxoSmithKline to invest in new, current UK sites (EN, Market Watch) |
| Infosys and Fabric Worldwide Chosen by GlaxoSmithKline to Support theDelivery of Digital Strategy (EN, CNX) |
| Statement - GlaxoSmithKline invests $12 Million in Canada for InfluenzaResearch (EN, CNX) |
| GlaxoSmithKline gets out of red in Q4 with US$1.98 bil. profit (EN, Chinapost) |
| Summary Box: GlaxoSmithKline swings to 4Q profit (EN, Yahoo) |
| Pharma: GlaxoSmithKline wieder in der Gewinnzone (Blick) |
| Profits surge at GlaxoSmithKline (EN, BBC) |
| GlaxoSmithKline back in profit in 4th quarter (EN, Yahoo) |
| GlaxoSmithKline schreibt schwarze Zahlen im vierten Quartal (Aktiencheck) |
| Murdoch's son leaving Glaxosmithkline board (EN, USA Today) |
| Has GlaxoSmithKline Become the Perfect Stock? (EN, MotleyFool) |
| GlaxoSmithKline: Dividend Dynamo or Blowup? (EN, MotleyFool) |
| GlaxoSmithKline - The Cheapest Major Healthcare Stock (EN, MotleyFool) |
| GlaxoSmithKline moves MENA offices to Turkey (EN, AMEinfo) |
| Europe stocks edge higher; GlaxoSmithKline off (EN, Market Watch) |
| GlaxoSmithKline, Theravance progress on Relovair (EN, Market Watch) |
| Is GlaxoSmithKline Good Enough for You? (EN, MotleyFool) |
| GlaxoSmithKline Inc. Launches $50 Million Life Sciences Innovation Fund inCanada (EN, CNX) |
| GlaxoSmithKline launches a new national $50 Million Life Sciences InnovationFund (EN, CNX) |
| Pharma News: Medivation, Dendreon, GlaxoSmithKline (EN, Forbes) |
| Avandia-Streit mit USA: GlaxoSmithKline zahlt (N-TV) |
| GlaxoSmithKline zahlt Milliarden wegen Diabetes-Mittel (N24) |
| GlaxoSmithKline to pay $3B to settle U.S. probes (EN, Market Watch) |
| AstraZeneca vs. GlaxoSmithKline (EN, MotleyFool) |
| Sales push up GlaxoSmithKline net profit 7% (EN, Chinapost) |
| Here's How GlaxoSmithKline Is Making You So Much Cash (EN, MotleyFool) |
| GlaxoSmithKline Q3 net profit up 7 percent (EN, Yahoo) |